Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Taurolidine 2% Catheter Locking to Prevent Catheter-related Bloodstream Infections in Patients on Home Parenteral Nutrition With a High Infection Risk and Those With a New Central Venous Access Device

NCT01826526 is registered in ClinicalTrials.gov with Geert Wanten as lead sponsor.

NCT NCT01826526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01826526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Taurolidine 2% Catheter Locking to Prevent Catheter-related Bloodstream Infections in Patients on Home Parenteral Nutrition With a High Infection Risk and Those With a New Central Venous Access Device
Lead sponsor
Geert Wanten
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2013
Completion date
November 30, 2016
Enrollment
105 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

catheter related blood stream infections